Latest News

Why Compounded Veterinary Medications Fall Short - Stability, Safety & Potency Risks in 2026 An Evidence-Based Review of Risks, Limitations, and Opportunities By Dr. Sarah Wade, Business Development & Alliance Manager This article was originally written for the 2026 Animal Health, Nutrition, and Technology Innovation Summit (AHNTI), where Eirgen Pharma was invited to contribute expert insights on a topic of their choice. We are pleased to share an expanded version for our br

Eirgen Pharma Announces HPRA Approval of New Facility in Waterford Waterford, Ireland – [March 2026]  — Eirgen Pharma is pleased to announce that its newly constructed manufacturing facility at the IDA Waterford Business Park has received full approval from the Health Products Regulatory Authority (HPRA). This certification confirms that the facility meets all Good Manufacturing Practice (GMP) requirements, authorizing the site to develop and manufacture investigational medic

Reflections from AHNTI 2026: Innovation, Customer-Centricity & The Evolving Landscape of Animal Health Last week, Eirgen Pharma attended the Animal Health, Nutrition and Technology Innovation Europe Summit ( AHNTI 2026)  for the first time as exhibitors. While it was our debut in this community, we’ve spent over a decade supporting both human and animal health companies in developing and manufacturing complex therapeutics. Being at AHNTI offered a unique chance to connect wi

Eirgen Pharma is delighted to announce our attendance at DCAT Week 2026, taking place in New York City from March 23rd to March 25th - the premier event where global pharmaceutical and biopharmaceutical leaders come together for strategic meetings, high-value collaborations, and forward-thinking industry insights.

We’re excited to share that Eirgen Pharma will be exhibiting at AHNTI 2026, taking place in London from March 2nd - 4th.

Competition Has Increased. Reliability Has Not. The oral solid dose (OSD) manufacturing market has become dramatically more competitive. More CDMO/CMO service providers have entered the space, bids are increasingly aggressive, and pricing pressure now touches nearly every program. Yet despite this expanding supplier landscape, one critical outcome has remained unchanged.